Ongoing Securities Investigation into PayPal Holdings, Inc. (PYPL) - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - February 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into PayPal Holdings, Inc. ("PayPal Holdings, Inc.") (NASDAQ: PYPL) concerning potential violations of the federal securities laws. The timeline of analyst expectations and company communications reveals a notable trajectory. On January 28, 2026, Rothschild & Co Redburn issued a downgrade, cutting PayPal's price target to $50 from $70. The following day, Morgan...
2026-02-09 12:16 AM EST
ATTENTION CORT Investors: Securities Fraud Investigation Underway - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - February 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated") (NASDAQ: CORT) concerning potential violations of the federal securities laws. What Happened? On December 31, 2025, Corcept announced it received a CRL from the FDA, denying approval of Corcept's new drug application for relacorilant as a treatment for patients with hypertension...
2026-02-09 12:11 AM EST
Investors in Boston Scientific Corporation (BSX) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today
New York, New York--(Newsfile Corp. - February 5, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE: BSX) concerning potential violations of the federal securities laws. On February 4, 2026, Boston Scientific reported fourth-quarter 2025 results. While the company exceeded analyst expectations for earnings per share and total revenue, its electrophysiology segment reported sales of $890...
2026-02-05 1:34 PM EST
Lost Money on Gartner, Inc. (IT)? Contact Levi & Korsinsky About Investigation
New York, New York--(Newsfile Corp. - February 5, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Gartner, Inc. ("Gartner, Inc.") (NYSE: IT) concerning potential violations of the federal securities laws. SEC Regulation G and Item 10(e) of Regulation S-K establish disclosure requirements for companies presenting non-GAAP financial measures. These rules require that adjusted metrics be reconciled to the most directly comparable GAAP measure and that GAAP...
2026-02-05 12:52 PM EST
CVLT ALERT: Levi & Korsinsky Investigates Commvault Systems, Inc. for Possible Securities Fraud Violations
New York, New York--(Newsfile Corp. - February 5, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Commvault Systems, Inc. ("Commvault Systems, Inc.") (NASDAQ: CVLT) concerning potential violations of the federal securities laws. On January 27, 2026, Commvault reported financial results for the third quarter of fiscal 2026 ended December 31, 2025, including "40% growth in SaaS ARR to $364 million," as noted by the Company's Chief Accounting Officer...
2026-02-05 10:52 AM EST
ATTENTION PYPL Investors: Securities Fraud Investigation Underway - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - February 4, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into PayPal Holdings, Inc. ("PayPal Holdings, Inc.") (NASDAQ: PYPL) concerning potential violations of the federal securities laws. PayPal announced on February 3, 2026, a surprise leadership change, replacing Chief Executive Officer Alex Chriss. PayPal noted in its announcement "the pace of change and execution was not in line with the Board's expectations."...
2026-02-04 3:55 PM EST
Lost Money on Corcept Therapeutics Incorporated (CORT)? Possible Fraud - Contact Levi & Korsinsky Today
New York, New York--(Newsfile Corp. - February 4, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated") (NASDAQ: CORT) concerning potential violations of the federal securities laws. What Happened? On December 31, 2025, Corcept announced it received a CRL from the FDA, denying approval of Corcept's new drug application for relacorilant as a treatment for patients with hypertension...
2026-02-04 3:31 PM EST
Fraud Investigation: Levi & Korsinsky Investigates Ashford Hospitality Trust, Inc. (AHT) on Behalf of Shareholders
New York, New York--(Newsfile Corp. - February 3, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Ashford Hospitality Trust, Inc. ("Ashford Hospitality Trust, Inc.") (NYSE: AHT) concerning potential violations of the federal securities laws. Ashford issued a press release on January 13, 2026, "announcing that it has extended its Highland mortgage loan secured by 18 hotels" and that "to preserve the Company's liquidity position as it evaluates strategic...
2026-02-03 2:53 PM EST
Shareholders Alert: Investigation Into Aquestive Therapeutics, Inc. (AQST) - Contact Levi & Korsinsky to Protect Your Rights
New York, New York--(Newsfile Corp. - February 2, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Aquestive Therapeutics, Inc. ("Aquestive Therapeutics, Inc.") (NASDAQ: AQST) concerning potential violations of the federal securities laws. What Happened? On January 9, 2026, Aquestive announced it received a letter from the FDA, identifying deficiencies in its NDA application that preclude labeling discussions and post-market commitments for Anaphylm, for...
2026-02-02 12:26 AM EST
Did You Suffer Losses in First Western Financial, Inc. (MYFW)? Contact Levi & Korsinsky About Securities Fraud Claims
New York, New York--(Newsfile Corp. - February 2, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into First Western Financial, Inc. ("First Western Financial, Inc.") (NASDAQ: MYFW) concerning potential violations of the federal securities laws. First Western reported its financial results for the fourth quarter of 2025 on January 22, 2026. Among other items, the Company reported quarterly earnings of $0.34 per share, missing analyst expectations. Following...
2026-02-02 12:21 AM EST
Lost Money on REGENXBIO Inc. (RGNX)? Possible Fraud - Contact Levi & Korsinsky Today
New York, New York--(Newsfile Corp. - February 2, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into REGENXBIO Inc. ("REGENXBIO Inc.") (NASDAQ: RGNX) concerning potential violations of the federal securities laws. On January 28, 2026, Regenxbio disclosed via Form 8-K that the FDA placed clinical holds on its RGX-111 and RGX-121 programs following the identification of a tumor in a trial participant. The disclosure prompted a 30-35% decline in the company's...
2026-02-02 12:18 AM EST
Did You Suffer Losses in Bgin Blockchain Limited (BGIN)? Contact Levi & Korsinsky About Securities Fraud Claims
New York, New York--(Newsfile Corp. - February 2, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Bgin Blockchain Limited ("Bgin Blockchain Limited") (NASDAQ: BGIN) concerning potential violations of the federal securities laws. Bgin released unaudited financial results on November 14, 2025, for the six months ended June 30, 2025, revealing that total revenue had declined roughly $96 million from the previous year, operating expenses increased 582.8%,...
2026-02-02 12:16 AM EST
Levi & Korsinsky Investigates Possible Securities Fraud by First Western Financial, Inc. (MYFW)
New York, New York--(Newsfile Corp. - January 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into First Western Financial, Inc. ("First Western Financial, Inc.") (NASDAQ: MYFW) concerning potential violations of the federal securities laws. First Western reported its financial results for the fourth quarter of 2025 on January 22, 2026. Among other items, the Company reported quarterly earnings of $0.34 per share, missing analyst expectations. Following...
2026-01-30 2:00 PM EST
RGNX ALERT: Levi & Korsinsky Investigates REGENXBIO Inc. for Possible Securities Fraud Violations
New York, New York--(Newsfile Corp. - January 29, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into REGENXBIO Inc. ("REGENXBIO Inc.") (NASDAQ: RGNX) concerning potential violations of the federal securities laws. On January 28, 2026, Regenxbio disclosed via Form 8-K that the FDA placed clinical holds on its RGX-111 and RGX-121 programs following the identification of a tumor in a trial participant. The disclosure prompted a 30-35% decline in the company's...
2026-01-29 11:41 AM EST
HDB ALERT: Levi & Korsinsky Investigates HDFC Bank Limited on Behalf of Shareholders Who Lost Money
New York, New York--(Newsfile Corp. - January 29, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into HDFC Bank Limited ("HDFC Bank Limited") (NYSE: HDB) concerning potential violations of the federal securities laws. During the post-merger integration period, HDFC Bank reported healthy credit expansion as the combined entity leveraged its enhanced distribution network and customer base. However, deposit growth did not keep pace with this loan book...
2026-01-29 11:16 AM EST
Investigation Underway: Aquestive Therapeutics, Inc. (AQST) - Contact Levi & Korsinsky Over Securities Law Violations
New York, New York--(Newsfile Corp. - January 26, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Aquestive Therapeutics, Inc. ("Aquestive Therapeutics, Inc.") (NASDAQ: AQST) concerning potential violations of the federal securities laws. What Happened? On January 9, 2026, Aquestive announced it received a letter from the FDA, identifying deficiencies in its NDA application that preclude labeling discussions and post-market commitments for Anaphylm, for...
2026-01-26 12:32 AM EST
Ongoing Ultragenyx Pharmaceutical Inc. (RARE) Investigation: Protect Your Rights - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - January 26, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Ultragenyx Pharmaceutical Inc. ("Ultragenyx Pharmaceutical Inc.") (NASDAQ: RARE) concerning potential violations of the federal securities laws. Ultragenyx reported the study results on December 29, 2025. Both studies failed to achieve their primary endpoint of a reduction in annualized clinical fracture rate against placebo in the Orbit study and against...
2026-01-26 12:30 AM EST
Ongoing Mereo BioPharma Group plc (MREO) Investigation: Protect Your Rights - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - January 26, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Mereo BioPharma Group plc ("Mereo BioPharma Group plc") (NASDAQ: MREO) concerning potential violations of the federal securities laws. On December 29, 2025, before the market opened, Mereo announced results from its Phase 3 ORBIT and COSMIC studies for setrusumab (UX143) in Osteogenesis Imperfecta (OI). The company reported that neither study failed to...
2026-01-26 12:27 AM EST
Fraud Investigation: Levi & Korsinsky Investigates Corcept Therapeutics Incorporated (CORT) on Behalf of Shareholders
New York, New York--(Newsfile Corp. - January 26, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated") (NASDAQ: CORT) concerning potential violations of the federal securities laws. What Happened? On December 31, 2025, Corcept announced it received a CRL from the FDA, denying approval of Corcept's new drug application for relacorilant as a treatment for patients with hypertension...
2026-01-26 12:24 AM EST
Levi & Korsinsky Launches Fraud Investigation on Behalf of Bgin Blockchain Limited (BGIN) Shareholders
New York, New York--(Newsfile Corp. - January 26, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Bgin Blockchain Limited ("Bgin Blockchain Limited") (NASDAQ: BGIN) concerning potential violations of the federal securities laws. Bgin released unaudited financial results on November 14, 2025, for the six months ended June 30, 2025, revealing that total revenue had declined roughly $96 million from the previous year, operating expenses increased 582.8%,...
2026-01-26 12:21 AM EST